ENABLING THE WAY FROM POLICY TO PRACTICE REALIZING THE GAPS AND LOOPHOLES IN BAN ON PROMOTION



Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial

BackgroundConestat alfa (ConA), a recombinant human C1 inhibitor, may prevent thromboinflammation.MethodsWe conducted a randomized, open-label, multi-national clinical trial in which hospitalized adults at risk for progression to severe COVID-19 were assigned in Lip Crayon a 2:1 ratio to receive either 3 days of ConA plus standard of care (SOC) or

read more


Tactical Planning of Three-Level Supply Chain considering Sanction Disruption and Shelf Life: A case Study of ATRA Drug Supply Chain

In the last two decades due to globalization of supply chain, enormous changes occurred in chains.Leaders in this field, always facing new risks and disorders that should prepare themselves to Pencil Sharpeners deal with them.In the recent years, sanctions as one of the most serious risks have damaged the supply chains.However, in the research rela

read more